Latest filing published 14 Mar 2025 for Repare Therapeutics Inc., €4,091.
Michael Zinda discloses dealings in Repare Therapeutics Inc. to SEC (Form 4). Between 22 June 2020 and 13 March 2025, the trades on record add up to 24 filings.
On the market, this insider has only sold: 5 sales, €770k in total. The rest of the record consists of 8 share grants and 10 option exercises. 2025 to date brings no purchases and 1 sale.
The record was last updated on 14 March 2025 with an open-market sale (€4,091) in Repare Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations